TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank83
3Y CAGR+4.4%
5Y CAGR+31.3%
Studio
Year-over-Year Change

Current ratio (current assets / current liabilities)

3Y CAGR
+4.4%/yr
Annual compound
5Y CAGR
+31.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
2 yr
Consecutive growthFair Value
PeriodValueYoY Change
20258.15+0.1%
20248.14+25.0%
20236.51-9.2%
20227.17-7.6%
20217.76+271.5%
20202.09-88.2%
201917.69-